KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Asset Utilization Ratio (2023 - 2025)

Biocryst Pharmaceuticals (BCRX) has disclosed Asset Utilization Ratio for 8 consecutive years, with 1.04 as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Asset Utilization Ratio rose 34.28% year-over-year to 1.04, compared with a TTM value of 1.04 through Mar 2025, up 34.28%, and an annual FY2024 reading of 0.89, changed N/A over the prior year.
  • Asset Utilization Ratio was 1.04 for Q1 2025 at Biocryst Pharmaceuticals, up from 0.92 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.26 in Q3 2024 and bottomed at 0.08 in Q3 2023.
  • Average Asset Utilization Ratio over 3 years is 0.67, with a median of 0.77 recorded in 2024.
  • The sharpest move saw Asset Utilization Ratio surged 1437.81% in 2024, then surged 34.28% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.55 in 2023, then surged by 65.92% to 0.92 in 2024, then grew by 13.0% to 1.04 in 2025.
  • Business Quant data shows Asset Utilization Ratio for BCRX at 1.04 in Q1 2025, 0.92 in Q4 2024, and 1.26 in Q3 2024.